And you can support it naturallywithout prescriptions, side effects, or shortcuts, but by changing the way you eat
Consistent sunscreen (SPF 50+ PA++++), skincare, and occasional maintenance drips help preserve your results long-term
Many people make the mistake of stopping treatment once pain decreases, only to experience flare-ups weeks later

Patient Assessment Protocol Comprehensive medical history with obesity-specific screening Physical examination including BMI, waist circumference, and body composition analysis Laboratory workup: complete metabolic panel, lipid panel, HbA1c, thyroid function, insulin levels Screening for sleep apnea, PCOS, Cushing syndrome, and other secondary causes of obesity Mental health screening for binge eating disorder and depression Readiness-to-change assessment Medication Formulary for Your Medical Weight Loss Program GLP-1 receptor agonists: Semaglutide (Wegovy), liraglutide (Saxenda), tirzepatide (Zepbound) Sympathomimetic agents: Phentermine (short-term), phentermine/topiramate (Qsymia) Other FDA-approved options: Naltrexone/bupropion (Contrave), orlistat (Xenical/Alli) Off-label considerations: Metformin, topiramate, bupropion (when clinically appropriate and properly documented) Your medical weight loss program's protocols should specify prescribing criteria, dosing escalation schedules, monitoring requirements, and discontinuation criteria for each medication

Daewoong told Korea Biomedical Review that the program is the first domestic long-acting GLP-1 obesity treatment to submit a phase 1 clinical trial application in Korea